Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $81,660,525    

Indirect Value

   $12,932,114,466      
Total Shares   142,789,105      
Total Value   $13,013,774,992      


Incyte Corp $32,141,876 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $301,214 Neurogene $16,634 Incyte Corp $32,141,876 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $301,214 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 23 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2011-12-30 4 OE $6.25 $425,038 I/I 68,006 539,130 0 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-02-03 4 B $6.29 $573,311 I/I 91,187 12,824,440 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-02-05 4 B $6.33 $284,657 I/I 45,000 12,894,240 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-07 4 B $6.37 $189,063 I/I 27,628 2,278,775 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-07 4 B $6.37 $478,630 I/I 69,943 6,081,798 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-07 4 B $6.37 $9,991 I/I 1,460 88,834 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-07 4 B $6.37 $15,212 I/I 2,223 203,310 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-07 4 B $6.37 $1,301 I/I 190 190,207 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-20 4 B $6.50 $2,944 I/I 453 98,836 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-20 4 B $6.50 $421,324 I/I 64,825 6,647,929 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-20 4 B $6.50 $58,105 I/I 8,940 2,458,400 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-20 4 B $6.50 $676 I/I 104 191,597 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-20 4 B $6.50 $13,376 I/I 2,058 221,303 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-02-02 4 B $6.52 $598,360 I/I 91,728 12,733,253 1.5 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-25 4 B $6.53 $664,135 I/I 101,144 15,232,546 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-27 4 B $6.64 $1,071,030 I/I 155,940 15,455,507 2.25 %
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-02-04 4 B $6.65 $164,915 I/I 24,800 12,849,240 1.5 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-26 4 B $6.71 $628,583 I/I 93,322 15,316,021 2.25 %
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-19 4 B $6.75 $3,039 I/I 450 98,383 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-19 4 B $6.75 $433,973 I/I 64,259 6,583,104 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-19 4 B $6.75 $59,850 I/I 8,862 2,449,460 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-19 4 B $6.75 $696 I/I 103 191,493 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-19 4 B $6.75 $13,770 I/I 2,039 219,245 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-20 4 B $6.87 $362,171 I/I 52,695 12,446,380 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-28 4 B $6.88 $172,015 I/I 25,000 12,641,525 1.5 -
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23  24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 23 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us